atropine has been researched along with fluorescein-5-isothiocyanate in 1 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (fluorescein-5-isothiocyanate) | Trials (fluorescein-5-isothiocyanate) | Recent Studies (post-2010) (fluorescein-5-isothiocyanate) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 8,493 | 33 | 2,090 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kharlamb, AB; Krauss, AH; Nieves, AL; Nilsson, SF; Toris, CB; Woodward, DF | 1 |
1 other study(ies) available for atropine and fluorescein-5-isothiocyanate
| Article | Year |
|---|---|
Prostanoid EP4 receptor stimulation produces ocular hypotension by a mechanism that does not appear to involve uveoscleral outflow.
Topics: Alprostadil; Animals; Anterior Chamber; Antihypertensive Agents; Aqueous Humor; Atropine; Ciliary Body; Dextrans; Dinoprostone; Disease Models, Animal; Female; Fluorescein-5-isothiocyanate; Fluorophotometry; Humans; Intraocular Pressure; Isometric Contraction; Macaca fascicularis; Muscle, Smooth; Ocular Hypotension; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Sclera; Tonometry, Ocular; Transfection; Uvea | 2009 |